Gene · 10
NIH grants1,535
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,535
Download this page as JSON| Grant | Title | NAT2 papers | Newest fiscal year |
|---|---|---|---|
| R01DK109392 | The Role in OAT1 in Uremia | 1 | 2025 |
| R01DK115679 | Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions | 1 | 2025 |
| R01DK127274 | A New Perspective on Leptin in Health and Disease | 1 | 2025 |
| R01DK134575 | A genomics-based strategy to precision phenotyping and drug repositioning in cardiometabolic diseases | 1 | 2025 |
| R01ES020867 | Metabolic Mechanisms of Naphthalene Toxicity in Lung | 1 | 2025 |
| R01ES025987 | Environmental DNA Lesions and Mutagenesis: Molecular Mechanisms of Lesion Recognition for Repair and Polymerase Bypass | 1 | 2025 |
| R01ES029294 | Metabolic activation of nitroarenes and Nrf2-Keap1 | 1 | 2025 |
| R01EY023557 | Primary Open Angle African-American Glaucoma Genetics Study Renewal | 1 | 2025 |
| R01HD041702 | Preterm Birth and Child Long-term Cardiometabolic Risk: Integrate Proteomics with Birth Cohort | 1 | 2025 |
| R01HD110567 | Integrative risk modeling for early prediction of endometriosis and its long-term health outcomes | 1 | 2025 |
| R01HL088521 | Risk Factors for Ischemic Stroke in Women | 1 | 2025 |
| R01HL109946 | Using genetics to discover mechanisms of abdominal aortic aneurysm | 1 | 2025 |
| R01LM012806 | Predicting Phenotype by Deep Learning Heterogeneous Multi-Omics Data | 1 | 2025 |
| R01NS034239 | Neuroprotective Immunity and HIV Dementia | 1 | 2025 |
| R24AI118397 | The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP) | 1 | 2025 |
| R25AI164610 | Enhancing Virology Training (ENVIT) through Summer Research | 1 | 2025 |
| R35GM134954 | Mining Actinobacterial Genomes for Natural Product Discovery and Biosynthesis | 1 | 2025 |
| R35GM143044 | Interindividual Variability in Drug Metabolism in Ethnically Diverse Populations | 1 | 2025 |
| R35GM145383 | Genomic and drug-drug interaction mechanisms of interindividual variability in drug disposition | 1 | 2025 |
| R50CA211241 | Cancer Pharmacokinetics Research Specialist | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/grants?page=9